Randomized Phase 2b Trial of CBL-514 Injection for Abdominal Subcutaneous Fat Reduction With Clinician- and Patient-reported Outcomes and MRI Assessment.

CBL-514 - Caliway Biopharmaceuticals

http://www.ncbi.nlm.nih.gov/pubmed/42159040

An-Yi Sheu; Chih-Yun Lu; Edward Ted Lain; Jeanine Downie; Joel Schlessinger; Michael Gold; Stacy Smith; Sue Ellen Cox; Yin-Chia Chou; Yu-Fang Ling; Z Paul Lorenc

May 21, 2026